Q&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

In our recent webinar, our panel of esteemed speakers broke stereotypes about Africa, discussed research-related trends and highlighted how clinical trials could benefit from the continent’s strengths.

Continue ReadingQ&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

New Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Several FHI Clinical team members attended the 6th Annual Global Forum on TB Vaccines. Based on their conversations and session attendance, they provide their thoughts on the future of tuberculosis prevention and vaccine development.

Continue ReadingNew Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Personal Choice in Research: Respecting Reasons for Participation and Nonparticipation

As researchers, we rely on the willingness of people to participate in our studies, and participant recruitment and retention continue to be one of the biggest challenges. There are numerous reasons for this, some that we can address and others that we might just have to accept.

Continue ReadingPersonal Choice in Research: Respecting Reasons for Participation and Nonparticipation

FHI Clinical Executive Team Members Visit the PREVAIL Network in Liberia

In the fall of 2021, a small team from FHI Clinical headed to Liberia to meet the FHI Clinical PREVAIL network team. Upon their return from visiting Liberia and each of the network sites, we asked the team some questions about the trip and their accomplishments.

Continue ReadingFHI Clinical Executive Team Members Visit the PREVAIL Network in Liberia

Supporting Evidence-Based Decisions About Pneumococcal Conjugate Vaccines

Results of recent studies that we supported focusing on vaccination against Streptococcus pneumoniae, a Gram-positive bacterium that is responsible for the majority of community-acquired pneumonia, were recently published, providing more evidence for health departments to use when developing their pediatric vaccination strategies.

Continue ReadingSupporting Evidence-Based Decisions About Pneumococcal Conjugate Vaccines

The Colors of COVID Town Hall Event: The Ethical Engagement of Minority Communities in COVID Clinical Research

In April, the Director of the Maryland Center for Health Equity’s Dr. Stephen B. Thomas partnered with FHI Clinical for a frank conversation by experts about COVID and how to encourage Brown and Black communities to participate in clinical research.

Continue ReadingThe Colors of COVID Town Hall Event: The Ethical Engagement of Minority Communities in COVID Clinical Research